Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wise

Showing results (291-300 of 822) with videos related to

Pageof 83
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|December 1, 1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|August 1, 1991
The in-vitro activity of cefdinir (FK482), a new oral cephalosporinR Wise, J M Andrews, D Thornber
The Australian & New Zealand Journal of Obstetrics & Gynaecology|November 27, 2008
Successful but limited use of external cephalic version in AucklandMichelle R Wise, Lynn Sadler, David Ansell
Antimicrobial Agents and Chemotherapy|May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326R Wise, J M Andrews, N Brenwald
The Journal of Antimicrobial Chemotherapy|July 1, 1989
Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acidJ M Diver, D Thornber, R Wise
The Journal of Antimicrobial Chemotherapy|March 1, 1987
Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin)N Manek, R Wise, I A Donovan
The Journal of Hospital Infection|September 1, 1985
A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomyJ Drumm, I A Donovan, R Wise
Current Opinion in Otolaryngology & Head and Neck Surgery|August 25, 2022
Impact of unilateral hearing loss in early developmentRebecca Bell, Maggie Mouzourakis, Sean R Wise
Lancet (London, England)|June 12, 1976
Ear-dropsA P Gillett, R Wise, G A Ayliffe
Pageof 83

Showing results (291-300 of 822) with videos related to

Sort By:
Pageof 83
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|December 1, 1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|August 1, 1991
The in-vitro activity of cefdinir (FK482), a new oral cephalosporinR Wise, J M Andrews, D Thornber
The Australian & New Zealand Journal of Obstetrics & Gynaecology|November 27, 2008
Successful but limited use of external cephalic version in AucklandMichelle R Wise, Lynn Sadler, David Ansell
Antimicrobial Agents and Chemotherapy|May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326R Wise, J M Andrews, N Brenwald
The Journal of Antimicrobial Chemotherapy|July 1, 1989
Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acidJ M Diver, D Thornber, R Wise
The Journal of Antimicrobial Chemotherapy|March 1, 1987
Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin)N Manek, R Wise, I A Donovan
The Journal of Hospital Infection|September 1, 1985
A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomyJ Drumm, I A Donovan, R Wise
Current Opinion in Otolaryngology & Head and Neck Surgery|August 25, 2022
Impact of unilateral hearing loss in early developmentRebecca Bell, Maggie Mouzourakis, Sean R Wise
Lancet (London, England)|June 12, 1976
Ear-dropsA P Gillett, R Wise, G A Ayliffe
Pageof 83